All In Biotech

Drug Trial Radar · NCT05412394

Once Weekly Infant Corticosteroid Trial for DMD

Phase-2 Trial of 5mg/kg/Week Prednisolone in Young Boys With DMD

Last checked: Nov 20, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

26

Planned (sponsor's estimate)

Start

Apr 30, 2021

Primary completion

Aug 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Anne M. ConnollyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Children's Hospital Medical Center, Cincinnati; Muscular Dystrophy Association; University of Texas; Virginia Commonwealth University; Ann & Robert H Lurie Children's Hospital of Chicago
First posted
Jun 9, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 1 month, up to 30 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The hypothesis tested here is that a lower dose of intermittent oral corticosteroids (5mg/kg/week) will be equally effective to the 10mg/kg/week dose.

Conditions

  • Duchenne Muscular Dystrophy

Interventions

  • PrednisoloneDrug

    Liquid, 5mg/kg per week, for one year

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The change from baseline to 24 months for the Gross Motor Scaled Score.Time frame: Baseline visit to 24 month visit

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Lurie Children's Hospital of Chicago

    Chicago, Illinois · Recruiting

  • University of Cincinnati

    Cincinnati, Ohio · Recruiting

  • Nationwide Children's Hospital

    Columbus, Ohio · Recruiting

  • University of Texas Southwestern

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.